These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29790007)

  • 1. Sublingual Immunotherapy Decreases Expression of Interleukin-33 in Children with Allergic Rhinitis.
    Wang Y; Li C; Xu Y; Xu D; Yang G; Liao F; Luo X
    Indian J Pediatr; 2018 Oct; 85(10):872-876. PubMed ID: 29790007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of leptin in allergic rhinitis during sublingual immunotherapy.
    Wen Y; Zhou L; Li Y; Li Z; Deng W; Zhang T
    Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2733-2738. PubMed ID: 30218387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of BAFF in pediatric patients with allergic rhinitis during sublingual immunotherapy.
    Luo R; Liu W; Wang J; Chen Y; Sun C; Zhou L; Li Y; Deng L
    Eur J Pediatr; 2014 Aug; 173(8):1033-40. PubMed ID: 24585100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased level of osteopontin in children with allergic rhinitis during sublingual immunotherapy.
    Wang C; Wang K; Liu S; Qin X; Chen K; Zhang T
    Int J Pediatr Otorhinolaryngol; 2016 Feb; 81():15-20. PubMed ID: 26810282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.
    Wang ZX; Shi H
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):407-411. PubMed ID: 28585143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of house dust mite sublingual immunotherapy on the TSLP-OX40L signaling pathway in patients with allergic rhinitis.
    Meng Q; Liu X; Li P; He L; Xie J; Gao X; Wu X; Su F; Liang Y
    Int Forum Allergy Rhinol; 2016 Aug; 6(8):862-70. PubMed ID: 27012942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of specifically reduced Th2 cell subsets in allergic rhinitis patients after sublingual immunotherapy.
    Ihara F; Sakurai D; Yonekura S; Iinuma T; Yagi R; Sakurai T; Ito T; Matsuura A; Morimoto Y; Arai T; Suzuki S; Katayama K; Nakayama T; Okamoto Y
    Allergy; 2018 Sep; 73(9):1823-1832. PubMed ID: 29517806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in type 2 innate lymphoid cells and serum cytokines in sublingual immunotherapy in pediatric patients with allergic rhinitis.
    Wang X; Shen Y; Hong S; Kang H; Ke X
    BMC Pediatr; 2023 Jan; 23(1):13. PubMed ID: 36624390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. House dust mite sublingual immunotherapy in allergic rhinitis.
    Cho SW; Han DH; Kim JW; Kim DY; Rhee CS
    Immunotherapy; 2018 Jun; 10(7):567-578. PubMed ID: 29562802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
    Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
    J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and cytokine responses to house dust mite sublingual immunotherapy.
    Potter PC; Baker S; Fenemore B; Nurse B
    Ann Allergy Asthma Immunol; 2015 Apr; 114(4):327-34. PubMed ID: 25661658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in children with allergic rhinitis and the change of TGF-β and IL-13 mRNA level].
    Wu YJ; Wang P; Liu ZX; Qiu SQ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 32(4):256-259. PubMed ID: 29798500
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
    Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
    J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The analysis of Th2 cell subsets in house dust mite allergic rhinitis patients after sublingual immunotherapy].
    Ihara F; Sakurai D; Okamoto Y
    Nihon Yakurigaku Zasshi; 2019; 154(1):12-16. PubMed ID: 31308344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in the prevalence of follicular regulatory T cells correlates with clinical efficacy of sublingual immunotherapy with house dust mites.
    Murao T; Kouzaki H; Arai H; Matsumoto K; Nakamura K; Kawakita K; Tojima I; Shimizu S; Yuta A; Shimizu T
    Int Forum Allergy Rhinol; 2024 Jan; 14(1):57-67. PubMed ID: 37345377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of TIM-1 predicates clinical efficacy of sublingual immunotherapy for allergic rhinitis in children.
    Lin Z; Zhou L; Luo X; Xia W; Chen D; Xu R; Wang J; Luo R; Xu G; Li H
    Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1345-9. PubMed ID: 23800473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.
    Emminger W; Hernández MD; Cardona V; Smeenk F; Fogh BS; Calderon MA; de Blay F; Backer V
    Int Arch Allergy Immunol; 2017; 174(1):35-44. PubMed ID: 28950268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.